Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shereen Ezzat

Showing results (181-190 of 249) with videos related to

Pageof 25
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2016
Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomasOzgur Mete, Karen Gomez-Hernandez, Walter Kucharczyk, et al.
Molecular Endocrinology (Baltimore, Md.)|March 15, 2014
FGFR4 polymorphic variants modulate phenotypic features of Cushing diseaseTae Nakano-Tateno, Toru Tateno, Maw Maw Hlaing, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|August 16, 2014
Current management of papillary thyroid microcarcinoma in CanadaMazin Merdad, Antoine Eskander, John De Almeida, et al.
Thyroid : Official Journal of the American Thyroid Association|September 24, 2010
Dietary iodine restriction in preparation for radioactive iodine treatment or scanning in well-differentiated thyroid cancer: a systematic reviewAnna M Sawka, Irada Ibrahim-Zada, Philip Galacgac, et al.
Endocrine Pathology|October 5, 2013
The role of mediators of cell invasiveness, motility, and migration in the pathogenesis of silent corticotroph adenomasOzgur Mete, Caroline Hayhurst, Hussein Alahmadi, et al.
The Journal of Clinical Endocrinology and Metabolism|March 16, 2012
Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in nonfunctioning pituitary adenomas: a high throughput TMA, immunohistochemical studyClaudia Ramírez, Sonia Cheng, Guadalupe Vargas, et al.
Endocrine Pathology|July 19, 2017
Pancreatic Neuroendocrine Tumor Producing Insulin and VasopressinOmalkhaire M Alshaikh, Ju-Yoon Yoon, Bryan A Chan, et al.
Cancer|July 27, 2004
The prevalence of pituitary adenomas: a systematic reviewShereen Ezzat, Sylvia L Asa, William T Couldwell, et al.
Archives of Pathology & Laboratory Medicine|April 30, 2011
Protocol for the examination of specimens from patients with primary pituitary tumorsVania Nosé, Shereen Ezzat, Eva Horvath, et al.
Virchows Archiv : an International Journal of Pathology|March 25, 2015
Familial pheochromocytoma and renal cell carcinoma syndrome: TMEM127 as a novel candidate gene for the associationKaren Gomez Hernandez, Shereen Ezzat, Chantal F Morel, et al.
Pageof 25

Showing results (181-190 of 249) with videos related to

Sort By:
Pageof 25
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2016
Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomasOzgur Mete, Karen Gomez-Hernandez, Walter Kucharczyk, et al.
Molecular Endocrinology (Baltimore, Md.)|March 15, 2014
FGFR4 polymorphic variants modulate phenotypic features of Cushing diseaseTae Nakano-Tateno, Toru Tateno, Maw Maw Hlaing, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|August 16, 2014
Current management of papillary thyroid microcarcinoma in CanadaMazin Merdad, Antoine Eskander, John De Almeida, et al.
Thyroid : Official Journal of the American Thyroid Association|September 24, 2010
Dietary iodine restriction in preparation for radioactive iodine treatment or scanning in well-differentiated thyroid cancer: a systematic reviewAnna M Sawka, Irada Ibrahim-Zada, Philip Galacgac, et al.
Endocrine Pathology|October 5, 2013
The role of mediators of cell invasiveness, motility, and migration in the pathogenesis of silent corticotroph adenomasOzgur Mete, Caroline Hayhurst, Hussein Alahmadi, et al.
The Journal of Clinical Endocrinology and Metabolism|March 16, 2012
Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in nonfunctioning pituitary adenomas: a high throughput TMA, immunohistochemical studyClaudia Ramírez, Sonia Cheng, Guadalupe Vargas, et al.
Endocrine Pathology|July 19, 2017
Pancreatic Neuroendocrine Tumor Producing Insulin and VasopressinOmalkhaire M Alshaikh, Ju-Yoon Yoon, Bryan A Chan, et al.
Cancer|July 27, 2004
The prevalence of pituitary adenomas: a systematic reviewShereen Ezzat, Sylvia L Asa, William T Couldwell, et al.
Archives of Pathology & Laboratory Medicine|April 30, 2011
Protocol for the examination of specimens from patients with primary pituitary tumorsVania Nosé, Shereen Ezzat, Eva Horvath, et al.
Virchows Archiv : an International Journal of Pathology|March 25, 2015
Familial pheochromocytoma and renal cell carcinoma syndrome: TMEM127 as a novel candidate gene for the associationKaren Gomez Hernandez, Shereen Ezzat, Chantal F Morel, et al.
Pageof 25